Childhood Acute Illness and Nutrition Network (CHAIN)

May 18, 2020 updated by: University of Oxford

Building the Evidence Base for Appropriate Care of the Sick, Undernourished Child in Limited Resource Settings

The CHAIN Network aims to identify modifiable biomedical and social factors driving the greatly increased risk of mortality among young undernourished children admitted to hospital with acute illness, as inpatients and after discharge. The study will inform priorities, risks and targeting for multi-faceted interventional trials.

CHAIN is a multi-centre cohort study with a nested case control analysis of stored biological samples. Study sites are located in Africa and South Asia. Children will be recruited at admission to hospital, stratified by nutritional status. Exposures will be assessed at admission, during hospitalisation, at discharge, and at two time points after discharge. The main outcomes of interest are mortality, re-admission to hospital and failure of nutritional recovery up to 180 days after discharge. To determine community health norms, an additional sample of children living in the same communities will be enrolled and assessed at one time point only.

Study Overview

Detailed Description

Despite an overall reduction of child mortality in LMICs, acutely-ill undernourished children continue to have a greatly elevated risk of death, both during hospitalisation and following discharge. However, we currently lack robust evidence for their management. Factors underlying the risks of mortality may relate to the acute illness itself, to children's longer term health trajectories, or to the home nutritional and care environment. The ultimate goal of the CHAIN Network is to identify and prioritize actionable intervention targets to reduce mortality among acutely ill undernourished children.

CHAIN's initial aim is to better understand the characteristics that determine increased risk of mortality in this vulnerable population, whether biological (related to infection, immunity and metabolism), nutritional (intake and anthropometry), health system factors (affecting management and discharge) or behavioural (community/caregiver interactions). CHAIN brings clinicians and scientists together from a variety of high-burden settings in Africa and South Asia. CHAIN will establish prospective cohorts of acutely ill young children across different geographies with differing population, social and environmental characteristics (stunted vs. wasting, rural vs. urban and presence of risk factors such as malaria and HIV).

Eight sites will be involved, including three hospitals in Kenya (Kilifi County, Migori County and Mbagathi District), two in Bangladesh (Matlab and the icddr,b Dhaka), and one in each of Uganda (Mulago), Malawi (Queen Elizabeth Community Hospital), Pakistan (Civil Hospital Karachi) and in West Africa (TBA). Site will enroll children at admission to hospital, and assess their clinical, social and economic status at admission, during hospitalisation, at discharge and during follow up for 180 days after discharge. The sites will also enrol children from the community to determine community norms (where ill and undernourished children would be expected to typically recover to). Protocols and procedures will be carefully harmonised across sites.

Children aged 2 months to 2 years admitted to hospital will be considered for inclusion and enrolment stratified by nutritional status. Following informed consent, baseline data of prognostic importance, including demographic and social information, a detailed clinical examination, anthropometry and measurement of vital signs, including pulse oximetry, will be collected using a standard proforma. A research blood sample will be collected together with the routine clinical blood draw to minimize the patient's discomfort. Rectal swabs and faecal sample will also be obtained from all children.

During admission, care will be provided according to WHO and national guidelines. Children will be reviewed daily and clinical features, progress and treatment received recorded on a structured case report form. In the event of death in hospital, a standard audit questionnaire will be completed. During admission, primary caregivers, usually the mother, will be interviewed screened for mental health problems. At discharge, anthropometry, a clinical assessment and blood, rectal swab and whole stool collected. Families will be linked with chronic care services where needed.

A home visit will be conducted for all participants, the GPS location recorded. Information homestead infrastructure, water and sanitation, population, livelihood, child care and socioeconomic characteristics. Children will be followed up at 45, 90 and 180 days after discharge. A health questionnaire will document health and social events, and dietary intake. Anthropometry, and faecal and blood samples collected.

Caregivers will be asked to attend the study hospital should the caregiver believes they may require hospitalisation. Study participants who are re-admitted to hospital will undergo standardised clinical assessment including history, examination and sample collection. In the event of death occurring outside the study hospital, a standard verbal autopsy (VA) will be completed by trained staff within 28 days of becoming aware of a death. VAs along with all available information will be used to ascribe causes of death.

Community participants will be invited to the study clinic for assessment. Following informed consent, they will have a clinical examination, anthropometry, blood and stool samples as children who are admitted. Children requiring non-urgent medical care will be eligible for inclusion as community participants but will be given basic treatment in the study clinic and/or referred to appropriate treatment centres. Study staff will refer community participants with incomplete vaccination or requiring care for chronic conditions as needed.

Several domains of exposure will be assessed: demographic, nutrition and metabolism; acute and chronic conditions; community-acquired and nosocomial infections (including antimicrobial resistance); gut function & dysbiosis; inflammation; responses to treatment; and the home care environment.

Successful design of an intervention package to address post-discharge child mortality will require attention social and economic agency and vulnerability, access and interactions with health services, and ethical considerations. A qualitative sub-study will examine these factors in context in rural and urban sites in Kenya and Bangladesh to identify critical social limitations and potential approaches to intervention. These data will inform the network's development, piloting, and implementation of interventions.

Additional sub-studies at a subset of sites will also examine in more detail the diagnosis and role of TB; and changes in functional immune responses; body composition and neurodevelopment during follow up.

Study Type

Observational

Enrollment (Actual)

4335

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dhaka, Bangladesh
        • icddr,b Dhaka Hospital
    • Chittagong
      • Dhaka, Chittagong, Bangladesh
        • Matlab Hospital
      • Kilifi, Kenya
        • Kilifi County Hospital
      • Migori, Kenya
        • Migori County Hospital
      • Nairobi, Kenya
        • Mbagathi District Hospital
      • Blantyre, Malawi
        • Queen Elizabeth Central Hospital
      • Karachi, Pakistan
        • Civil Hospital Karachi
      • Kampala, Uganda
        • Mulago Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 months to 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Hospital and post-discharge cohort: Children being admitted to hospital.

Community reference participants: Children living in the same communities as those recruited into the hospitalized cohort.

Description

Inclusion criteria (hospitalized participants):

  • Children 2 months-23 months.
  • Admitted to hospital.
  • Planning to remain within the hospital catchment area and willing to come for specified visits during the 6 month follow up period.
  • Parent or guardian consents on child's behalf.

Inclusion criteria (community participants):

  • Aged 2 to 23 months
  • Living in the same community as the acutely ill children recruited.
  • Not having an acute illness requiring hospital admission
  • Absence of known, but untreated HIV or TB
  • Not admitted to hospital within the last 14 days
  • Not previously included in the study
  • Parent or guardian consents on child's behalf.

Exclusion Criteria (all participants):

  • Requiring immediate resuscitation at admission to hospital*
  • Unable to tolerate oral feeds while in his/her usual state of health
  • Underlying terminal illness that in the opinion of the treating physician is likely to lead to death within 6 months (e.g., cancer, congenital heart disease)
  • Diagnosed with a condition that in the opinion of the treating physician is likely to require surgery within 6 months
  • Diagnosed chromosomal abnormality (syndromically or genetically diagnosed abnormality)
  • Primary reason for admission is poisoning, trauma or a surgical condition
  • Previously enrolled in this study
  • Sibling currently or previously enrolled in this study

(* children requiring resuscitation will be defined as those with on-going cardiac or pulmonary arrest or judged to be peri-arrest by the attending physician)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Hospitalized children with severe wasting or kwashiorkor (SWK)
Children recruited at admission to hospital and followed up for 180 days post-discharge.
Community reference participants (CP)
Children recruited from the community who are seen a single appointment in the community.
Hospitalized children with moderate wasting (MW)
Children recruited at admission to hospital and followed up for 180 days post-discharge.
Hospitalized children without wasting (NW)
Children recruited at admission to hospital and followed up for 180 days post-discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: Up to 30 days after admission to hospital
Assessed using clinical and civil records and verbal autopsy
Up to 30 days after admission to hospital
Mortality
Time Frame: Up to 180 days after discharge from hospital
Assessed using clinical and civil records and verbal autopsy
Up to 180 days after discharge from hospital

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rehospitalization
Time Frame: Up to 180 days after discharge from hospital
Number of participants, assessed from direct observation or clinical records
Up to 180 days after discharge from hospital
Change in weight-for-height z-score
Time Frame: Up to 180 days after discharge from hospital
Post-discharge growth
Up to 180 days after discharge from hospital
Change in length-for-age z-score
Time Frame: Up to 180 days after discharge from hospital
Post-discharge growth
Up to 180 days after discharge from hospital
Change in mid-upper arm circumference
Time Frame: Up to 180 days after discharge from hospital
Post-discharge growth
Up to 180 days after discharge from hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2016

Primary Completion (Actual)

January 31, 2020

Study Completion (Anticipated)

October 31, 2020

Study Registration Dates

First Submitted

March 8, 2017

First Submitted That Met QC Criteria

July 3, 2017

First Posted (Actual)

July 5, 2017

Study Record Updates

Last Update Posted (Actual)

May 20, 2020

Last Update Submitted That Met QC Criteria

May 18, 2020

Last Verified

May 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumonia

3
Subscribe